Differential responses of pulmonary vascular cells from PAH patients and controls to TNFα and the effect of the BET inhibitor JQ1
Abstract Background Pulmonary arterial hypertension (PAH) encompasses a group of diseases characterized by raised pulmonary vascular resistance, resulting from vascular remodelling and inflammation. Bromodomain and extra-terminal (BET) proteins are required for the expression of a subset of NF-κB-in...
Main Authors: | Sharon Mumby, Frederic Perros, Julien Grynblat, Gregoire Manaud, Alberto Papi, Paolo Casolari, Gaetano Caramori, Marc Humbert, S. John Wort, Ian M. Adcock |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-07-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12931-023-02499-y |
Similar Items
-
Making a diagnosis in PAH
by: J. S. R. Gibbs
Published: (2007-08-01) -
Revealing the pathogenic changes of PAH based on multiomics characteristics
by: Li Zhang, et al.
Published: (2019-07-01) -
The Role of Regulatory T Cells in Pulmonary Arterial Hypertension
by: Haihua Qiu, et al.
Published: (2019-12-01) -
The Functions of BET Proteins in Gene Transcription of Biology and Diseases
by: Ka Lung Cheung, et al.
Published: (2021-09-01) -
Fatal dissection of the pulmonary artery in pulmonary arterial hypertension
by: B. Degano, et al.
Published: (2009-09-01)